The company will still have some catching up to do, as LM-299 is early in clinical development, with a phase 1 trial ...

A new study out of Harvard Medical School is opening the door for cancer patients with a rare but dangerous heart condition ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Dr. Watanabe and his team from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

Peter Hosein, M.D., a medical oncologist specializing in pancreatic cancer at Sylvester Comprehensive Cancer Center, ...

The EFTISARC-NEO trial, with a data cut-off of 20 October 2024, also showed 71.4% of patients achieved a pathologic response ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

In recent years, the role of gut microbiota has become the major area of focus in human health and diseases. Numerous studies have highlighted the importance of gut microbiota in the regulation of ...

Lyell Duffy only had nine weeks with his family after a melanoma diagnosis. The family wants to help others avoid the same ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

Mom of 3 was brutally tortured before being set ablaze in Manipur: Autopsy A horrifying incident in Manipur's Jiribam district has left the community reeling after a 31-year-old mother of three ...